iiinova — where your digital self keeps evolving

Reposted by Rogier van Doorn

ACORN @acorn-amr.bsky.social · 03/06/2026

ACORN AMR attributable mortality analyses out in CID: doi.org/10.1093/cid/... We highlight the complexity of documenting burden of AMR in LMICs. BSIs are associated with ⬆️mortality overall but AMR-BSI not so much @hrvd.bsky.social @wellcometrust.bsky.social @cghr.ox.ac.uk @ndm.ox.ac.uk

academic.oup.com

Validate User

136

Reposted by Rogier van Doorn

Centre for Tropical Medicine and Global Health @tropicalmedicine.ox.ac.uk · 17/12/2025

#ResearchHighlight from @moru-mip.bsky.social, @oucru.bsky.social, @kemriwellcome.bsky.social Prospective characterisation of drug-resistant bloodstream infections in Africa and Asia #ACORN2 a surveillance network assessment 👉 www.ndm.ac/tropmed.res-hi Paper 👉 www.sciencedirect.com/science/arti...

043

Rogier van Doorn @hrvd.bsky.social · 10/04/2025

Landed in Wien (Vienna) for 5 days of Microbiology and Infectious diseases at ESCMID Global #escmidglobal

000

Reposted by Rogier van Doorn

Paul Adamson MD MPH @padamsonmd.bsky.social · 17/02/2025

Drug-resistant #gonorrhea is an urgent issue, threatening our empiric treatment options. Resistance to ceftriaxone is rapidly increasing in the Asia-Pacific region. Happy to share our study from Vietnam, now out in @jidjournal.bsky.social academic.oup.com/jid/article/... #IDsky #STIsky #AMR

academic.oup.com

High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024

This study, from Hanoi, Vietnam between 2023-2024, observed a 27% prevalence of ceftriaxone resistance among 352 Neisseria gonorrhoeae isolates. Whole-geno

12711

Reposted by Rogier van Doorn

ACORN @acorn-amr.bsky.social · 22/01/2025

Hello from the ACORN AMR Investigators We are delighted to share our first results preprint, covering the >40,000 clinical infection episodes and BSI / AMR data captured by our 19 sites across 9 African and Asian countries dx.doi.org/10.2139/ssrn... More coming soon!

dx.doi.org

ACORN2: Prospective Clinically Oriented Antimicrobial Resistance Surveillance Data from 19 Hospitals across Africa and Asia

<div> Background: Antimicrobial resistance (AMR) is a global health threat requiring both clinical and laboratory data to determine burden and inform intervent

014